Titel

Merkliste
1 Ergebnisse

Phase II Open-Label Study of Pembrolizumab in Treatment-Ref..:

Le, Dung, T ; Kim, Won ; Cutsem, Eric, Van...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41389-018-0079-x. , 2021

Link: https://hal.science/hal-03991735

RT Journal
T1 <Title>Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164 ; Syndrome de Lynch : quoi de neuf ?</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftccsdartic:oai:HAL:hal-03991735v1&Exemplar=1&LAN=DE
				
A1 Le, Dung, T
A1 Kim, Won
A1 Cutsem, Eric, Van
A1 Geva, Ravit
A1 Jäger, Dirk
A1 Hara, Hiroki
A1 Burge, Matthew
A1 O'Neil, Bert
A1 Kavan, Petr
A1 Yoshino, Takayuki
A1 Guimbaud, Rosine
A1 Taniguchi, Hiroya
A1 Elez, Elena
A1 Al-Batran, Salah-Eddin
A1 Boland, Patrick, M
A1 Crocenzi, Todd
A1 Atreya, Chloe, E
A1 Cui, Yi
A1 Dai, Tong
A1 Marinello, Patricia
A1 Diaz, Luis, A
A1 André, Thierry
PB HAL CCSD; American Society of Clinical Oncology
YR 2021
K1 colon cancer
K1 recurrence
K1 prognosis
K1 Pseudoprogression
K1 Microsatellite instability
K1 Mismatch repair
K1 Immunotherapy
K1 PD1
K1 CTLA-4
K1 [SDV.CAN]Life Sciences [q-bio]/Cancer
K1 [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy
K1 [SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and Gastroenterology
JF info:eu-repo/semantics/altIdentifier/doi/10.1038/s41389-018-0079-x
LK http://dx.doi.org/https://hal.science/hal-03991735
DO https://hal.science/hal-03991735
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)